Advisory board

Executive Karla Martin Joins Advisory Board of NYC Fashion Brand Ramy Brook

Retrieved on: 
Wednesday, March 13, 2024

NEW YORK, March 13, 2024 /PRNewswire/ -- Ramy Brook, a leading fashion brand known for its luxurious, stylish and sexy contemporary designs, proudly announces the addition of C-Suite advisor and executive Karla Martin to its Advisory Board.

Key Points: 
  • NEW YORK, March 13, 2024 /PRNewswire/ -- Ramy Brook, a leading fashion brand known for its luxurious, stylish and sexy contemporary designs, proudly announces the addition of C-Suite advisor and executive Karla Martin to its Advisory Board.
  • "We are absolutely delighted to have Karla Martin join our Advisory Board," says Ramy Brook Sharp, the Founder and Creative Director behind the eponymous brand.
  • "I am honored to join Ramy Brook's Advisory Board," said Karla Martin.
  • I look forward to working closely with the team to drive innovation and further elevate the Ramy Brook brand."

Diagnostics Direct, LLC Announces Formation of a Medical Advisory Board

Retrieved on: 
Wednesday, March 13, 2024

STONE HARBOR, N.J., March 13, 2024 /PRNewswire/ -- Diagnostics Direct LLC, a leading provider of diagnostic testing solutions, is proud to announce the formation of its distinguished Medical Advisory Board.

Key Points: 
  • STONE HARBOR, N.J., March 13, 2024 /PRNewswire/ -- Diagnostics Direct LLC, a leading provider of diagnostic testing solutions, is proud to announce the formation of its distinguished Medical Advisory Board.
  • Board members have expressed their enthusiasm for the impact they can have on the syphilis epidemic by working with Diagnostics Direct:
    Dr. Jeffrey Klausner remarked, "I am pleased to lead the Diagnostics Direct Medical Advisory Board.
  • Dr. Leandro Mena shared, "I am thrilled to join the Diagnostics Direct Medical Advisory Board, where our shared dedication to revolutionizing point-of-care testing and enhancing syphilis diagnostics is key.
  • The formation of the Medical Advisory Board by Diagnostics Direct signifies a major step forward in combating the spread of syphilis through innovative, accessible testing solutions.

Therabody Expands Investment in Science with $10 Million Research Pledge, Scientific Partnerships and Official Scientific Advisory Board

Retrieved on: 
Tuesday, March 12, 2024

LOS ANGELES, March 12, 2024 /PRNewswire/ -- Therabody, the leader in wellness technology, announced today the investment of more than $10M to fund initiatives that will continue to drive innovation and the scientific validation of their products. The company also announced the formalization of their Scientific Advisory Board and, significantly, a partnership with the American College of Sports Medicine (ACSM), the global research leader in the field of exercise, physical fitness and sports medicine.

Key Points: 
  • In an evolving regulatory landscape, Therabody believes that science is essential for leading the way forward as technology will transform healthcare over the next decade.
  • Their $10 million investment in scientific research will drive an integrated strategy for scientific leadership in the industry with funds put toward scientific and clinical research studies across beauty, wellness and athletic performance over the next several years.
  • Our Scientific Advisory Board, along with our significant investment in scientific research and partnerships, will ensure we remain at the forefront of our industry and dedicated to developing the most effective, scientifically validated products available today and in the future," said Monty Sharma, President and CEO of Therabody.
  • Therabody has completed 21 scientific studies to date with 26 currently in progress.

Therabody Expands Investment in Science with $10 Million Research Pledge, Scientific Partnerships and Official Scientific Advisory Board

Retrieved on: 
Tuesday, March 12, 2024

LOS ANGELES, March 12, 2024 /PRNewswire/ -- Therabody, the leader in wellness technology, announced today the investment of more than $10M to fund initiatives that will continue to drive innovation and the scientific validation of their products. The company also announced the formalization of their Scientific Advisory Board and, significantly, a partnership with the American College of Sports Medicine (ACSM), the global research leader in the field of exercise, physical fitness and sports medicine.

Key Points: 
  • In an evolving regulatory landscape, Therabody believes that science is essential for leading the way forward as technology will transform healthcare over the next decade.
  • Their $10 million investment in scientific research will drive an integrated strategy for scientific leadership in the industry with funds put toward scientific and clinical research studies across beauty, wellness and athletic performance over the next several years.
  • Our Scientific Advisory Board, along with our significant investment in scientific research and partnerships, will ensure we remain at the forefront of our industry and dedicated to developing the most effective, scientifically validated products available today and in the future," said Monty Sharma, President and CEO of Therabody.
  • Therabody has completed 21 scientific studies to date with 26 currently in progress.

Spatially Health Names Leigh Ann Ruggles to Its Advisory Board to Drive Healthcare Innovation and Growth

Retrieved on: 
Tuesday, March 12, 2024

MIAMI, March 12, 2024 /PRNewswire-PRWeb/ -- Spatially Health, a cloud-based, health equity platform focused on identifying and addressing social determinants of health (SDOH) and health equity barriers, is excited to announce the appointment of healthcare leader Leigh Ann Ruggles as its newest Advisory Board member. Leigh Ann will play a pivotal role in shaping the company's strategic vision and decision-making.

Key Points: 
  • MIAMI, March 12, 2024 /PRNewswire-PRWeb/ -- Spatially Health , a cloud-based, health equity platform focused on identifying and addressing social determinants of health (SDOH) and health equity barriers, is excited to announce the appointment of healthcare leader Leigh Ann Ruggles as its newest Advisory Board member.
  • As a proven healthcare leader with expertise in driving business growth and market share for digital health companies, Leigh Ann is dedicated to identifying tangible solutions to tackle the increase in healthcare expenses, limited accessibility, and disparities in care.
  • "I am honored to welcome Leigh Ann Ruggles to our Advisory Board," stated Dr. Hillit Meidar-Alfi , the CEO and co-founder of Spatially Health.
  • Before Onlife Health, Leigh Ann led the Go-to-Market (GTM) organizations for both MDLIVE, a leading telehealth provider, as well as Verizon Mobile Health.

HIMALAYA TECHNOLOGIES PARTNERS WITH RENOVI! TO TARGET MEDICAL TOURISM MARKET IN CARIBBEAN; ADDS CEO TO ADVISORY BOARD

Retrieved on: 
Monday, March 11, 2024

Additionally, the Company has appointed Renovi!’s CEO, David Burns, Ph.D., to its Advisory Board to guide its entry into this multi-billion dollar market, assist on mergers and acquisitions including a potential combination of Renovi!

Key Points: 
  • Additionally, the Company has appointed Renovi!’s CEO, David Burns, Ph.D., to its Advisory Board to guide its entry into this multi-billion dollar market, assist on mergers and acquisitions including a potential combination of Renovi!
  • The availability of the newest medical technologies and the cheaper cost of treatment in emerging nations are key market drivers enhancing market growth.
  • reinvents traditional outpatient rehabilitation by offering patients a “recovery vacation” at an upscale, beachfront medical resort with healthy diet, exercise, community and exceptional medical care.
  • The Dominican Republic is uniquely positioned as a medical tourism destination because of its low costs, proximity to the U.S., a well-established tourism infrastructure, and tax incentives for tourism investments.

4BIO Capital Strengthens Advisory Board and Investment Team

Retrieved on: 
Monday, March 11, 2024

LONDON, 11 March 2024 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm unlocking the treatments of the future by investing in advanced therapies and other emerging technologies, announces today the appointments of biopharmaceutical industry veteran Abbas Hussain and world-leading vectorology expert Leszek Lisowski, PhD MBA to its Advisory Board.

Key Points: 
  • LONDON, 11 March 2024 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm unlocking the treatments of the future by investing in advanced therapies and other emerging technologies, announces today the appointments of biopharmaceutical industry veteran Abbas Hussain and world-leading vectorology expert Leszek Lisowski, PhD MBA to its Advisory Board.
  • Along with the appointment of Abbas and Leszek, 4BIO is also pleased to announce the promotion of Dr Natalie Johnston to Principal.
  • I am honoured to be joining the 4BIO Capital Advisory Board alongside such esteemed members and look forward to working closely with the entire team to support the firm’s portfolio companies and identify the disruptive companies of the future.”
    Leszek Lisowski, newly appointed Advisory Board member added: “I have watched the 4BIO Capital team’s success over the last 8 years with admiration and I am excited to support them as an Advisory Board member.
  • Fostering the development of our team is core to 4BIO’s philosophy, ensuring we have the very best talent to help drive tomorrow’s innovation.

Mitesco Continues Key Initiatives, Updates

Retrieved on: 
Thursday, March 7, 2024

“We are making progress in our key initiatives, including full compliance with our reporting requirements, evaluating our capital structure, and reviewing various acquisition candidates.

Key Points: 
  • “We are making progress in our key initiatives, including full compliance with our reporting requirements, evaluating our capital structure, and reviewing various acquisition candidates.
  • Regarding our compliance activities, we are well into the work effort to complete our Annual Report on Form 10k.
  • Our accounting support team is reviewing the records required, and we are applying new resources.
  • As shareholders and investors, we intend to make decisions that reflect the best interest of all participants.”

CoreCivic Appoints Catherine Hernandez-Blades and Alexander R. Fischer to its Board of Directors; CoreCivic Also Announces Planned Retirement of Long-Term Board Member Donna Alvarado

Retrieved on: 
Thursday, March 7, 2024

Both Ms. Hernandez-Blades and Mr. Fischer are expected to join various board committees in the future.

Key Points: 
  • Both Ms. Hernandez-Blades and Mr. Fischer are expected to join various board committees in the future.
  • "We are pleased to have Catherine and Alex join our Board of Directors," said Damon Hininger, CoreCivic's President and Chief Executive Officer.
  • "Catherine brings decades of executive leadership experience in government relations, communications, and marketing in both the private and the public sectors.
  • Catherine also provides community support as a board member at several non-profits.

Brera Holdings Adds Luxury Lifestyle Executive Massimo Ferragamo to Its All-Star Advisory Board

Retrieved on: 
Wednesday, March 6, 2024

Ferragamo joins the recently named Advisory Board all-star team members Alan Rothenberg, Paul Tosetti, Giuseppe Rossi and Marshall Geller.

Key Points: 
  • Ferragamo joins the recently named Advisory Board all-star team members Alan Rothenberg, Paul Tosetti, Giuseppe Rossi and Marshall Geller.
  • “In addition to leading one of the most famous global luxury fashion houses, with his family, Massimo Ferragamo’s name is synonymous with elevated lifestyle, so his valued perspective is the perfect addition to our all-star Advisory Board.
  • Massimo Ferragamo is the Chairman of Ferragamo USA, Inc., which he has led since 2000, after serving as that company’s President since 1985.
  • “We are truly blessed to strengthen an already amazing Advisory Board and are pleased to welcome Massimo, Alan, Paul, Marshall, and Giuseppe to Brera’s Advisory Board at this exciting time.